Kamada (KMDA) FCF Margin (QoQ) (2013 - 2026)
Kamada (KMDA) FCF Margin (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.34 Bn | 43.37 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.80 Bn | 40.14 Bn | 2.15 Bn |
| 3 | Zoetis | 32.38 Bn | 30.70 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.94 Bn | 18.06 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.61 Bn | 15.22 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.01 Bn | 11.48 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Kamada | 470.39 Mn | 440.92 Mn | 22.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,755.00 |
| Mar 31, 2026 | -978.00 |
| Dec 31, 2025 | -1,850.00 |
| Sep 30, 2025 | 2,977.00 |
| Jun 30, 2025 | -215.00 |
| Mar 31, 2025 | -1,948.00 |
| Dec 31, 2024 | -3,666.00 |
| Sep 30, 2024 | 5,827.00 |
| Jun 30, 2024 | -977.00 |
| Mar 31, 2024 | -519.00 |
| Dec 31, 2023 | 801.00 |
| Sep 30, 2023 | -62.00 |
| Jun 30, 2023 | 761.00 |
| Mar 31, 2023 | -216.00 |
| Dec 31, 2022 | 216.00 |
| Sep 30, 2022 | -4,287.00 |
| Jun 30, 2022 | 2,159.00 |
| Mar 31, 2022 | 1,893.00 |
| Dec 31, 2021 | 734.00 |
| Sep 30, 2021 | 305.00 |